Obsessive Compulsive disorder Flashcards
Point prevalence
- 1-3% of adults
- 1-2% children and adolescents
Lifetime prevalence of OCD
- 2-3%
- 4th most commonly prevalent psychiatric disorder in epidemiological studies
Gender ratio of OCD
- roughly equal in clinical samples
- females dominate in community populations 1.5:1
- males with OCD show earlier onset and trend toward more tics and poorer outcome than females
Presentation of OCD
4 factor model
- aggressive, sexual and religious obsessions and checking compulsions
- symmetry and ordering obsessions and compulsions
- contamination obsessions and cleaning compulsions
- hoarding obsessions and compulsions
Neuroimaging
-hypermetabolism of basal ganglia structures (caudate)
D2 antagonism
-D2 antagonists such as clozapine can cause secondary OCD-like symptoms in some patients
OCD spectrum disorders
- those associated with somatic preoccupation e.g AN, BDD, hypochondriasis
- those associated with neurological disorders e.g Tourettes, Sydenham’s chorea and ASD
- Those associated with impulse control disorders e.g paraphilias, kleptomania, pathological gambling
- Anankastic personality
PANDAS
- Paediatric autoimmune neuropsychiatric disorders associated with strep infection
- autoantibodies bind to basal ganglia
- produces tics, OCD symptoms and anxiety
Diagnostic criteria for PANDAS
- presence of OCD or Tic disorder
- Onset between 3 years of age and the beginning of puberty
- abrupt onset of symptoms or a course characterised by dramatic exacerbations of symptoms
- the onset of symptoms is temporally related to infection with GABHS
- Abnormal results of neurological examination (hyperactivity, choreiform movements and tics) during exacerbation
Testing for PANDAS
- AntiDNAseB
- Antistreptolysin O titres are elevated
Mild to moderate OCD treatment
Step 1: self help
Step 2: CBT with ERP
Step 3: SSRIs +/- CBT
Severe OCD treatment
Step 1: SSRIs+/- CBT
Responders: continue SSRI for 1-2 years +/- booster CBT
Non-responders: switch to different SSRI or clomipramine
SSRIs and OCD
- 60-70% patients experience some degree of improvement after SSRI treatment
- NNT is 6-12
Antipsychotic augmentation
- indicated if no response seen after a three month trial of a maximal dose of SSRI
- also helpful in Tics